Sign inGet started

UROV

Urovant Sciences Ltd.CIK 1740547 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
38

AI insights for UROV PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for UROV
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Johnston WaltSee Remarks5$0$02021-03-29
Haag-Molkenteller CorneliaCMO/Urovant Sciences, Inc.10$0$02021-03-29
Kurstjens SefDirector11$0$02021-03-29
Smith Bryan E.GC/Urovant Sciences, Inc.14$0$02021-03-29
Robinson James A. Jr.PEO;CEO/Urovant Sciences, Inc.9$0$02021-03-29
Hindman James M.Director6$0$02021-03-29
Legault PierreDirector11$0$02021-03-29
OCAMPO CHRISTINEPFAO;CAO/Urovant Sciences,Inc.9$0$02021-03-29
BANSAL AJAYSee Remarks6$0$02021-03-29
POTTER MYRTLE SDirector10$0$02021-03-29
Sumitovant Biopharma Ltd.10% Owner3$1.35M$02020-02-19
Katkin KeithPEO;CEO/Urovant Sciences, Inc.12$0$1.53M2020-02-19
Roivant Sciences Ltd.10% Owner28$38.75M$02019-12-27
Torti FrankDirector2$0$02019-07-09
QVT Financial Investment Cayman Ltd.10% Owner9$427.8K$02019-06-19
Dexcel Pharma Technologies Ltd.10% Owner19$38.39M$02019-06-19
SoftBank Vision Fund L.P.10% Owner10$37.92M$02019-06-19
Lo Andrew10% Owner27$38.75M$02019-06-19
VGE III Portfolio Ltd.10% Owner7$37.76M$02019-06-19
Machado Patrick10% Owner27$38.75M$02019-06-19
HALVORSEN OLE ANDREAS10% Owner11$37.98M$02019-06-19
SVF Holdings (UK) LLP10% Owner6$354.6K$02019-06-14
Shabet Rose Sharon10% Owner3$177.3K$02019-06-14
QVT Associates GP LLC10% Owner17$819.4K$02019-06-14
Viking Global Equities LP10% Owner3$177.3K$02019-06-14
Viking Global Opportunities Portfolio GP LLC10% Owner3$177.3K$02019-06-11
Viking Long Fund GP LLC10% Owner3$177.3K$02019-06-11
SVF GP (Jersey) Ltd10% Owner3$166.0K$02019-06-06
Viking Global Opportunities Illiquid Investments Sub-Master LP10% Owner7$328.9K$02019-06-06
VIKING GLOBAL PERFORMANCE LLC10% Owner3$166.0K$02019-06-06
Viking Global Equities Master Ltd.10% Owner4$138.9K$02019-06-03
SVF Investments (UK) Ltd10% Owner8$301.8K$02019-06-03
VIKING GLOBAL INVESTORS LP10% Owner7$249.4K$02019-06-03
Dexxon Holdings Ltd.10% Owner8$355.8K$02019-05-29
Ott David C.10% Owner3$99.98M$02019-05-23
McFadden Michael E.CCO/Urovant Sciences, Inc.2$0$02019-01-06
Ebersole NoriSVP;CHRO/Urovant Sciences, Inc2$0$02019-01-06
QVT Fund V LP10% Owner1$37.50M$02018-10-01

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
POTTER MYRTLE SDirector D To issuer deriv2021-03-292021-03-3150,000— $00SEC↗
POTTER MYRTLE SDirector D To issuer deriv2021-03-292021-03-3125,000— $00SEC↗
POTTER MYRTLE SDirector D To issuer deriv2021-03-292021-03-3115,000— $00SEC↗
OCAMPO CHRISTINEPAO; CAO/Urovant Sciences,In D To issuer deriv2021-03-292021-03-313,750— $00SEC↗
OCAMPO CHRISTINEPAO; CAO/Urovant Sciences,In D To issuer deriv2021-03-292021-03-31133,500— $00SEC↗
OCAMPO CHRISTINEPAO; CAO/Urovant Sciences,In D To issuer deriv2021-03-292021-03-3170,000— $00SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. D To issuer deriv2021-03-292021-03-3193,450— $00SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. D To issuer deriv2021-03-292021-03-3120,000— $00SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. D To issuer deriv2021-03-292021-03-313,500— $00SEC↗
BANSAL AJAYSee Remarks D To issuer deriv2021-03-292021-03-31140,000— $00SEC↗
Hindman James M.Director D To issuer deriv2021-03-292021-03-3161,000— $00SEC↗
Hindman James M.Director D To issuer deriv2021-03-292021-03-3115,000— $00SEC↗
Johnston WaltSee Remarks D To issuer deriv2021-03-292021-03-3169,197— $00SEC↗
Kurstjens SefDirector D To issuer deriv2021-03-292021-03-3113,350— $00SEC↗
Kurstjens SefDirector D To issuer deriv2021-03-292021-03-3136,650— $00SEC↗
Kurstjens SefDirector D To issuer deriv2021-03-292021-03-3115,000— $00SEC↗
Kurstjens SefDirector D To issuer deriv2021-03-292021-03-3125,000— $00SEC↗
Haag-Molkenteller CorneliaCMO/Urovant Sciences, Inc. D To issuer deriv2021-03-292021-03-31146,850— $00SEC↗
Haag-Molkenteller CorneliaCMO/Urovant Sciences, Inc. D To issuer deriv2021-03-292021-03-31100,000— $00SEC↗
Haag-Molkenteller CorneliaCMO/Urovant Sciences, Inc. D To issuer deriv2021-03-292021-03-311,000— $00SEC↗
Legault PierreDirector D To issuer deriv2021-03-292021-03-3125,000— $00SEC↗
Legault PierreDirector D To issuer deriv2021-03-292021-03-3115,000— $00SEC↗
Legault PierreDirector D To issuer deriv2021-03-292021-03-3136,650— $00SEC↗
Legault PierreDirector D To issuer deriv2021-03-292021-03-3113,350— $00SEC↗
Robinson James A. Jr.PEO;CEO/Urovant Sciences, In D To issuer deriv2021-03-292021-03-31845,732— $00SEC↗
Robinson James A. Jr.PEO;CEO/Urovant Sciences, In D To issuer deriv2021-03-292021-03-3150,000— $00SEC↗
Robinson James A. Jr.PEO;CEO/Urovant Sciences, In D To issuer deriv2021-03-292021-03-3125,000— $00SEC↗
POTTER MYRTLE SDirector D To issuer2021-03-292021-03-3112,480— $00SEC↗
POTTER MYRTLE SDirector D To issuer2021-03-292021-03-319,000— $00SEC↗
OCAMPO CHRISTINEPAO; CAO/Urovant Sciences,In D To issuer2021-03-292021-03-319,810— $00SEC↗
OCAMPO CHRISTINEPAO; CAO/Urovant Sciences,In D To issuer2021-03-292021-03-3168,971— $00SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. D To issuer2021-03-292021-03-319,341— $00SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. D To issuer2021-03-292021-03-31115,106— $00SEC↗
BANSAL AJAYSee Remarks D To issuer2021-03-292021-03-31115,222— $00SEC↗
BANSAL AJAYSee Remarks D To issuer2021-03-292021-03-3124,876— $00SEC↗
Hindman James M.Director D To issuer2021-03-292021-03-319,000— $00SEC↗
Johnston WaltSee Remarks D To issuer2021-03-292021-03-31492— $00SEC↗
Johnston WaltSee Remarks D To issuer2021-03-292021-03-31108,647— $00SEC↗
Kurstjens SefDirector D To issuer2021-03-292021-03-3112,480— $00SEC↗
Kurstjens SefDirector D To issuer2021-03-292021-03-319,000— $00SEC↗
Haag-Molkenteller CorneliaCMO/Urovant Sciences, Inc. D To issuer2021-03-292021-03-31129,745— $00SEC↗
Haag-Molkenteller CorneliaCMO/Urovant Sciences, Inc. D To issuer2021-03-292021-03-3111,603— $00SEC↗
Legault PierreDirector D To issuer2021-03-292021-03-319,000— $00SEC↗
Legault PierreDirector D To issuer2021-03-292021-03-3112,480— $00SEC↗
Robinson James A. Jr.PEO;CEO/Urovant Sciences, In D To issuer2021-03-292021-03-318,385— $00SEC↗
Robinson James A. Jr.PEO; CEO/Urovant Sciences, I F Tax w/h2021-01-102021-01-124,095$16.11 $66.0K8,385SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. F Tax w/h2021-01-072021-01-084,761$16.09 $76.6K124,447SEC↗
Haag-Molkenteller CorneliaCMO/Urovant Sciences, Inc. F Tax w/h2021-01-072021-01-085,810$16.09 $93.5K141,348SEC↗
Kurstjens SefDirector A Award deriv2020-07-212020-07-2315,000— $015,000SEC↗
POTTER MYRTLE SDirector A Award deriv2020-07-212020-07-2315,000— $015,000SEC↗
Legault PierreDirector A Award deriv2020-07-212020-07-2315,000— $015,000SEC↗
Hindman James M.Director A Award deriv2020-07-212020-07-2315,000— $015,000SEC↗
Kurstjens SefDirector A Award2020-07-212020-07-239,000— $021,480SEC↗
POTTER MYRTLE SDirector A Award2020-07-212020-07-239,000— $021,480SEC↗
Legault PierreDirector A Award2020-07-212020-07-239,000— $021,480SEC↗
Hindman James M.Director A Award2020-07-212020-07-239,000— $09,000SEC↗
Johnston WaltSVP, Commercial, USI A Award deriv2020-06-022020-06-0369,197— $069,197SEC↗
Johnston WaltSVP, Commercial, USI A Award2020-06-022020-06-03108,647— $0108,647SEC↗
Hindman James M.Director A Award deriv2020-06-012020-06-0161,000— $061,000SEC↗
BANSAL AJAYPFO;CFO/Urovant Sciences, In A Award2020-05-012020-05-0463,659— $0138,659SEC↗
OCAMPO CHRISTINEPAO;CAO/Urovant Sciences, In A Award2020-05-012020-05-0444,346— $077,179SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. A Award2020-05-012020-05-0477,606— $0127,606SEC↗
Haag-Molkenteller CorneliaCMO/Urovant Sciences, Inc. A Award2020-05-012020-05-0483,149— $0145,277SEC↗
Robinson James A. Jr.PEO;CEO/Urovant Sciences, In A Award deriv2020-03-232020-03-25845,732— $0845,732SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. M Exercise deriv2020-02-192020-02-2150,000— $020,000SEC↗
Katkin KeithPEO;CEO/Urovant Sciences, In M Exercise deriv2020-02-192020-02-21180,000— $0701,254SEC↗
Sumitovant Biopharma Ltd.10% Owner P Buy2020-02-192020-02-2175,212$13.08 $983.8K22,963,263SEC↗
Sumitovant Biopharma Ltd.10% Owner P Buy2020-02-192020-02-2112,873$13.08 $168.4K22,872,886SEC↗
Sumitovant Biopharma Ltd.10% Owner P Buy2020-02-192020-02-2115,165$13.08 $198.4K22,888,051SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. J Other2020-02-192020-02-2115,165$13.08 $198.4K50,000SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. F Tax w/h2020-02-192020-02-2134,835$13.08 $455.6K65,165SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. M Exercise2020-02-192020-02-2150,000$6.88 $344.0K100,000SEC↗
Katkin KeithPEO;CEO/Urovant Sciences, In J Other2020-02-192020-02-2175,212$13.08 $983.8K199,680SEC↗
Katkin KeithPEO;CEO/Urovant Sciences, In F Tax w/h2020-02-192020-02-21104,788$13.08 $1.37M274,892SEC↗
Katkin KeithPEO;CEO/Urovant Sciences, In M Exercise2020-02-192020-02-21180,000$3.86 $694.8K379,680SEC↗
Kurstjens SefDirector A Award2020-01-102020-01-1412,480— $012,480SEC↗
Legault PierreDirector A Award2020-01-102020-01-1412,480— $012,480SEC↗
POTTER MYRTLE SDirector A Award2020-01-102020-01-1412,480— $012,480SEC↗
Robinson James A. Jr.Director A Award2020-01-102020-01-1412,480— $012,480SEC↗
Smith Bryan E.GC/Urovant Sciences, Inc. A Award2020-01-072020-01-0950,000— $050,000SEC↗
OCAMPO CHRISTINEPAO;CAO/Urovant Sciences, In A Award2020-01-072020-01-0932,833— $032,833SEC↗
Haag-Molkenteller CorneliaCMO/Urovant Sciences, Inc. A Award2020-01-072020-01-0962,128— $062,128SEC↗
Katkin KeithPEO;CEO/Urovant Sciences, In A Award2020-01-072020-01-09199,680— $0199,680SEC↗
Roivant Sciences Ltd.10% Owner S Sale2019-12-272019-12-3122,860,013— $00SEC↗
Katkin KeithPEO;CEO/Urovant Sciences, In M Exercise deriv2019-12-092019-12-11120,000— $0881,254SEC↗
Katkin KeithPEO;CEO/Urovant Sciences, In M Exercise2019-12-092019-12-11120,000$3.86 $463.2K120,000SEC↗
Katkin KeithPEO;CEO/Urovant Sciences, In S Sale2019-12-092019-12-11120,000$12.78 $1.53M0SEC↗
BANSAL AJAYPFO;CFO/Urovant Sciences, In A Award deriv2019-11-052019-11-05140,000— $0140,000SEC↗
BANSAL AJAYPFO;CFO/Urovant Sciences, In A Award2019-11-052019-11-0575,000— $075,000SEC↗
Kurstjens SefDirector A Award deriv2019-07-092019-07-1125,000— $025,000SEC↗
Legault PierreDirector A Award deriv2019-07-092019-07-1125,000— $025,000SEC↗
POTTER MYRTLE SDirector A Award deriv2019-07-092019-07-1125,000— $025,000SEC↗
Robinson James A. Jr.Director A Award deriv2019-07-092019-07-1125,000— $025,000SEC↗
Torti FrankDirector A Award deriv2019-07-092019-07-1125,000— $025,000SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-192019-06-194,957$8.17 $40.5K22,860,013SEC↗
Lo Andrew10% Owner P Buy2019-06-192019-06-194,957$8.17 $40.5K22,860,013SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-192019-06-194,957$8.17 $40.5K22,860,013SEC↗
HALVORSEN OLE ANDREAS10% Owner P Buy2019-06-192019-06-194,957$8.17 $40.5K22,860,013SEC↗
VGE III Portfolio Ltd.10% Owner P Buy2019-06-192019-06-194,957$8.17 $40.5K22,860,013SEC↗
SoftBank Vision Fund L.P.10% Owner P Buy2019-06-192019-06-194,957$8.17 $40.5K22,860,013SEC↗
Machado Patrick10% Owner P Buy2019-06-192019-06-194,957$8.17 $40.5K22,860,013SEC↗
QVT Financial Investment Cayma10% Owner P Buy2019-06-192019-06-194,957$8.17 $40.5K22,860,013SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-182019-06-196,706$8.21 $55.1K22,855,056SEC↗
Lo Andrew10% Owner P Buy2019-06-182019-06-196,706$8.21 $55.1K22,855,056SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-182019-06-196,706$8.21 $55.1K22,855,056SEC↗
HALVORSEN OLE ANDREAS10% Owner P Buy2019-06-182019-06-196,706$8.21 $55.1K22,855,056SEC↗
VGE III Portfolio Ltd.10% Owner P Buy2019-06-182019-06-196,706$8.21 $55.1K22,855,056SEC↗
SoftBank Vision Fund L.P.10% Owner P Buy2019-06-182019-06-196,706$8.21 $55.1K22,855,056SEC↗
Machado Patrick10% Owner P Buy2019-06-182019-06-196,706$8.21 $55.1K22,855,056SEC↗
QVT Financial Investment Cayma10% Owner P Buy2019-06-182019-06-196,706$8.21 $55.1K22,855,056SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-172019-06-196,541$8.53 $55.8K22,848,350SEC↗
Lo Andrew10% Owner P Buy2019-06-172019-06-196,541$8.53 $55.8K22,848,350SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-172019-06-196,541$8.53 $55.8K22,848,350SEC↗
HALVORSEN OLE ANDREAS10% Owner P Buy2019-06-172019-06-196,541$8.53 $55.8K22,848,350SEC↗
VGE III Portfolio Ltd.10% Owner P Buy2019-06-172019-06-196,541$8.53 $55.8K22,848,350SEC↗
SoftBank Vision Fund L.P.10% Owner P Buy2019-06-172019-06-196,541$8.53 $55.8K22,848,350SEC↗
Machado Patrick10% Owner P Buy2019-06-172019-06-196,541$8.53 $55.8K22,848,350SEC↗
QVT Financial Investment Cayma10% Owner P Buy2019-06-172019-06-196,541$8.53 $55.8K22,848,350SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-142019-06-147,144$7.91 $56.5K22,841,809SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-142019-06-147,144$7.91 $56.5K22,841,809SEC↗
Machado Patrick10% Owner P Buy2019-06-142019-06-147,144$7.91 $56.5K22,841,809SEC↗
Shabet Rose Sharon10% Owner P Buy2019-06-142019-06-147,144$7.91 $56.5K22,841,809SEC↗
Viking Global Equities LP10% Owner P Buy2019-06-142019-06-147,144$7.91 $56.5K22,841,809SEC↗
QVT Associates GP LLC10% Owner P Buy2019-06-142019-06-147,144$7.91 $56.5K22,841,809SEC↗
Lo Andrew10% Owner P Buy2019-06-142019-06-147,144$7.91 $56.5K22,841,809SEC↗
SVF Holdings (UK) LLP10% Owner P Buy2019-06-142019-06-147,144$7.91 $56.5K22,841,809SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-132019-06-147,367$7.95 $58.6K22,834,665SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-132019-06-147,367$7.95 $58.6K22,834,665SEC↗
Machado Patrick10% Owner P Buy2019-06-132019-06-147,367$7.95 $58.6K22,834,665SEC↗
Shabet Rose Sharon10% Owner P Buy2019-06-132019-06-147,367$7.95 $58.6K22,834,665SEC↗
Viking Global Equities LP10% Owner P Buy2019-06-132019-06-147,367$7.95 $58.6K22,834,665SEC↗
QVT Associates GP LLC10% Owner P Buy2019-06-132019-06-147,367$7.95 $58.6K22,834,665SEC↗
Lo Andrew10% Owner P Buy2019-06-132019-06-147,367$7.95 $58.6K22,834,665SEC↗
SVF Holdings (UK) LLP10% Owner P Buy2019-06-132019-06-147,367$7.95 $58.6K22,834,665SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-122019-06-147,500$8.30 $62.3K22,827,298SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-122019-06-147,500$8.30 $62.3K22,827,298SEC↗
Machado Patrick10% Owner P Buy2019-06-122019-06-147,500$8.30 $62.3K22,827,298SEC↗
Shabet Rose Sharon10% Owner P Buy2019-06-122019-06-147,500$8.30 $62.3K22,827,298SEC↗
Viking Global Equities LP10% Owner P Buy2019-06-122019-06-147,500$8.30 $62.3K22,827,298SEC↗
QVT Associates GP LLC10% Owner P Buy2019-06-122019-06-147,500$8.30 $62.3K22,827,298SEC↗
Lo Andrew10% Owner P Buy2019-06-122019-06-147,500$8.30 $62.3K22,827,298SEC↗
SVF Holdings (UK) LLP10% Owner P Buy2019-06-122019-06-147,500$8.30 $62.3K22,827,298SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-112019-06-117,189$8.58 $61.7K22,819,798SEC↗
Lo Andrew10% Owner P Buy2019-06-112019-06-117,189$8.58 $61.7K22,819,798SEC↗
Viking Long Fund GP LLC10% Owner P Buy2019-06-112019-06-117,189$8.58 $61.7K22,819,798SEC↗
Viking Global Opportunities Po10% Owner P Buy2019-06-112019-06-117,189$8.58 $61.7K22,819,798SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-112019-06-117,189$8.58 $61.7K22,819,798SEC↗
Machado Patrick10% Owner P Buy2019-06-112019-06-117,189$8.58 $61.7K22,819,798SEC↗
SVF Holdings (UK) LLP10% Owner P Buy2019-06-112019-06-117,189$8.58 $61.7K22,819,798SEC↗
QVT Associates GP LLC10% Owner P Buy2019-06-112019-06-117,189$8.58 $61.7K22,819,798SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-102019-06-117,500$8.35 $62.6K22,812,609SEC↗
Lo Andrew10% Owner P Buy2019-06-102019-06-117,500$8.35 $62.6K22,812,609SEC↗
Viking Long Fund GP LLC10% Owner P Buy2019-06-102019-06-117,500$8.35 $62.6K22,812,609SEC↗
Viking Global Opportunities Po10% Owner P Buy2019-06-102019-06-117,500$8.35 $62.6K22,812,609SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-102019-06-117,500$8.35 $62.6K22,812,609SEC↗
Machado Patrick10% Owner P Buy2019-06-102019-06-117,500$8.35 $62.6K22,812,609SEC↗
SVF Holdings (UK) LLP10% Owner P Buy2019-06-102019-06-117,500$8.35 $62.6K22,812,609SEC↗
QVT Associates GP LLC10% Owner P Buy2019-06-102019-06-117,500$8.35 $62.6K22,812,609SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-072019-06-116,649$7.97 $53.0K22,805,109SEC↗
Lo Andrew10% Owner P Buy2019-06-072019-06-116,649$7.97 $53.0K22,805,109SEC↗
Viking Long Fund GP LLC10% Owner P Buy2019-06-072019-06-116,649$7.97 $53.0K22,805,109SEC↗
Viking Global Opportunities Po10% Owner P Buy2019-06-072019-06-116,649$7.97 $53.0K22,805,109SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-072019-06-116,649$7.97 $53.0K22,805,109SEC↗
Machado Patrick10% Owner P Buy2019-06-072019-06-116,649$7.97 $53.0K22,805,109SEC↗
SVF Holdings (UK) LLP10% Owner P Buy2019-06-072019-06-116,649$7.97 $53.0K22,805,109SEC↗
QVT Associates GP LLC10% Owner P Buy2019-06-072019-06-116,649$7.97 $53.0K22,805,109SEC↗
Machado Patrick10% Owner P Buy2019-06-062019-06-067,082$8.00 $56.7K22,798,460SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-062019-06-067,082$8.00 $56.7K22,798,460SEC↗
Lo Andrew10% Owner P Buy2019-06-062019-06-067,082$8.00 $56.7K22,798,460SEC↗
VIKING GLOBAL PERFORMANCE LLC10% Owner P Buy2019-06-062019-06-067,082$8.00 $56.7K22,798,460SEC↗
Viking Global Opportunities Il10% Owner P Buy2019-06-062019-06-067,082$8.00 $56.7K22,798,460SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-062019-06-067,082$8.00 $56.7K22,798,460SEC↗
SVF GP (Jersey) Ltd10% Owner P Buy2019-06-062019-06-067,082$8.00 $56.7K22,798,460SEC↗
QVT Financial Investment Cayma10% Owner P Buy2019-06-062019-06-067,082$8.00 $56.7K22,798,460SEC↗
Machado Patrick10% Owner P Buy2019-06-052019-06-066,540$8.02 $52.5K22,791,378SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-052019-06-066,540$8.02 $52.5K22,791,378SEC↗
Lo Andrew10% Owner P Buy2019-06-052019-06-066,540$8.02 $52.5K22,791,378SEC↗
VIKING GLOBAL PERFORMANCE LLC10% Owner P Buy2019-06-052019-06-066,540$8.02 $52.5K22,791,378SEC↗
Viking Global Opportunities Il10% Owner P Buy2019-06-052019-06-066,540$8.02 $52.5K22,791,378SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-052019-06-066,540$8.02 $52.5K22,791,378SEC↗
SVF GP (Jersey) Ltd10% Owner P Buy2019-06-052019-06-066,540$8.02 $52.5K22,791,378SEC↗
QVT Financial Investment Cayma10% Owner P Buy2019-06-052019-06-066,540$8.02 $52.5K22,791,378SEC↗
Machado Patrick10% Owner P Buy2019-06-042019-06-067,500$7.59 $56.9K22,784,838SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-042019-06-067,500$7.59 $56.9K22,784,838SEC↗
Lo Andrew10% Owner P Buy2019-06-042019-06-067,500$7.59 $56.9K22,784,838SEC↗
VIKING GLOBAL PERFORMANCE LLC10% Owner P Buy2019-06-042019-06-067,500$7.59 $56.9K22,784,838SEC↗
Viking Global Opportunities Il10% Owner P Buy2019-06-042019-06-067,500$7.59 $56.9K22,784,838SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-042019-06-067,500$7.59 $56.9K22,784,838SEC↗
SVF GP (Jersey) Ltd10% Owner P Buy2019-06-042019-06-067,500$7.59 $56.9K22,784,838SEC↗
QVT Financial Investment Cayma10% Owner P Buy2019-06-042019-06-067,500$7.59 $56.9K22,784,838SEC↗
Lo Andrew10% Owner P Buy2019-06-032019-06-035,424$7.71 $41.8K22,777,338SEC↗
QVT Associates GP LLC10% Owner P Buy2019-06-032019-06-035,424$7.71 $41.8K22,777,338SEC↗
VIKING GLOBAL INVESTORS LP10% Owner P Buy2019-06-032019-06-035,424$7.71 $41.8K22,777,338SEC↗
Viking Global Equities Master 10% Owner P Buy2019-06-032019-06-035,424$7.71 $41.8K22,777,338SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-06-032019-06-035,424$7.71 $41.8K22,777,338SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-06-032019-06-035,424$7.71 $41.8K22,777,338SEC↗
Machado Patrick10% Owner P Buy2019-06-032019-06-035,424$7.71 $41.8K22,777,338SEC↗
SVF Investments (UK) Ltd10% Owner P Buy2019-06-032019-06-035,424$7.71 $41.8K22,777,338SEC↗
Lo Andrew10% Owner P Buy2019-05-312019-06-035,071$7.70 $39.0K22,771,914SEC↗
QVT Associates GP LLC10% Owner P Buy2019-05-312019-06-035,071$7.70 $39.0K22,771,914SEC↗
VIKING GLOBAL INVESTORS LP10% Owner P Buy2019-05-312019-06-035,071$7.70 $39.0K22,771,914SEC↗
Viking Global Equities Master 10% Owner P Buy2019-05-312019-06-035,071$7.70 $39.0K22,771,914SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-05-312019-06-035,071$7.70 $39.0K22,771,914SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-312019-06-035,071$7.70 $39.0K22,771,914SEC↗
Machado Patrick10% Owner P Buy2019-05-312019-06-035,071$7.70 $39.0K22,771,914SEC↗
SVF Investments (UK) Ltd10% Owner P Buy2019-05-312019-06-035,071$7.70 $39.0K22,771,914SEC↗
Lo Andrew10% Owner P Buy2019-05-302019-06-03300$8.91 $2.7K22,766,843SEC↗
Lo Andrew10% Owner P Buy2019-05-302019-06-036,951$7.97 $55.4K22,766,543SEC↗
QVT Associates GP LLC10% Owner P Buy2019-05-302019-06-03300$8.91 $2.7K22,766,843SEC↗
QVT Associates GP LLC10% Owner P Buy2019-05-302019-06-036,951$7.97 $55.4K22,766,543SEC↗
VIKING GLOBAL INVESTORS LP10% Owner P Buy2019-05-302019-06-03300$8.91 $2.7K22,766,843SEC↗
VIKING GLOBAL INVESTORS LP10% Owner P Buy2019-05-302019-06-036,951$7.97 $55.4K22,766,543SEC↗
Viking Global Equities Master 10% Owner P Buy2019-05-302019-06-03300$8.91 $2.7K22,766,843SEC↗
Viking Global Equities Master 10% Owner P Buy2019-05-302019-06-036,951$7.97 $55.4K22,766,543SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-05-302019-06-036,951$7.97 $55.4K22,766,543SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-05-302019-06-03300$8.91 $2.7K22,766,843SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-302019-06-036,951$7.97 $55.4K22,766,543SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-302019-06-03300$8.91 $2.7K22,766,843SEC↗
Machado Patrick10% Owner P Buy2019-05-302019-06-03300$8.91 $2.7K22,766,843SEC↗
Machado Patrick10% Owner P Buy2019-05-302019-06-036,951$7.97 $55.4K22,766,543SEC↗
SVF Investments (UK) Ltd10% Owner P Buy2019-05-302019-06-036,951$7.97 $55.4K22,766,543SEC↗
SVF Investments (UK) Ltd10% Owner P Buy2019-05-302019-06-03300$8.91 $2.7K22,766,843SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-292019-05-296,882$7.55 $52.0K22,759,592SEC↗
QVT Financial Investment Cayma10% Owner P Buy2019-05-292019-05-296,882$7.55 $52.0K22,759,592SEC↗
Lo Andrew10% Owner P Buy2019-05-292019-05-296,882$7.55 $52.0K22,759,592SEC↗
VIKING GLOBAL INVESTORS LP10% Owner P Buy2019-05-292019-05-296,882$7.55 $52.0K22,759,592SEC↗
VGE III Portfolio Ltd.10% Owner P Buy2019-05-292019-05-296,882$7.55 $52.0K22,759,592SEC↗
Dexxon Holdings Ltd.10% Owner P Buy2019-05-292019-05-296,882$7.55 $52.0K22,759,592SEC↗
Machado Patrick10% Owner P Buy2019-05-292019-05-296,882$7.55 $52.0K22,759,592SEC↗
SoftBank Vision Fund L.P.10% Owner P Buy2019-05-292019-05-296,882$7.55 $52.0K22,759,592SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-282019-05-293,807$7.68 $29.2K22,752,710SEC↗
QVT Financial Investment Cayma10% Owner P Buy2019-05-282019-05-293,807$7.68 $29.2K22,752,710SEC↗
Lo Andrew10% Owner P Buy2019-05-282019-05-293,807$7.68 $29.2K22,752,710SEC↗
VIKING GLOBAL INVESTORS LP10% Owner P Buy2019-05-282019-05-293,807$7.68 $29.2K22,752,710SEC↗
VGE III Portfolio Ltd.10% Owner P Buy2019-05-282019-05-293,807$7.68 $29.2K22,752,710SEC↗
Dexxon Holdings Ltd.10% Owner P Buy2019-05-282019-05-293,807$7.68 $29.2K22,752,710SEC↗
Machado Patrick10% Owner P Buy2019-05-282019-05-293,807$7.68 $29.2K22,752,710SEC↗
SoftBank Vision Fund L.P.10% Owner P Buy2019-05-282019-05-293,807$7.68 $29.2K22,732,710SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-242019-05-293,796$7.70 $29.2K22,748,903SEC↗
QVT Financial Investment Cayma10% Owner P Buy2019-05-242019-05-293,796$7.70 $29.2K22,748,903SEC↗
Lo Andrew10% Owner P Buy2019-05-242019-05-293,796$7.70 $29.2K22,748,903SEC↗
VIKING GLOBAL INVESTORS LP10% Owner P Buy2019-05-242019-05-293,796$7.70 $29.2K22,748,903SEC↗
VGE III Portfolio Ltd.10% Owner P Buy2019-05-242019-05-293,796$7.70 $29.2K22,748,903SEC↗
Dexxon Holdings Ltd.10% Owner P Buy2019-05-242019-05-293,796$7.70 $29.2K22,748,903SEC↗
Machado Patrick10% Owner P Buy2019-05-242019-05-293,796$7.70 $29.2K22,748,903SEC↗
SoftBank Vision Fund L.P.10% Owner P Buy2019-05-242019-05-293,796$7.70 $29.2K22,748,903SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-232019-05-234,802$7.76 $37.3K22,745,107SEC↗
Lo Andrew10% Owner P Buy2019-05-232019-05-234,802$7.76 $37.3K22,745,107SEC↗
QVT Associates GP LLC10% Owner P Buy2019-05-232019-05-234,802$7.76 $37.3K22,745,107SEC↗
Machado Patrick10% Owner P Buy2019-05-232019-05-234,802$7.76 $37.3K22,745,107SEC↗
HALVORSEN OLE ANDREAS10% Owner P Buy2019-05-232019-05-234,802$7.76 $37.3K22,745,107SEC↗
Ott David C.10% Owner P Buy2019-05-232019-05-234,802$7.76 $37.3K0SEC↗
SoftBank Vision Fund L.P.10% Owner P Buy2019-05-232019-05-234,802$7.76 $37.3K22,745,107SEC↗
Dexxon Holdings Ltd.10% Owner P Buy2019-05-232019-05-284,802$7.76 $37.3K22,745,107SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-222019-05-235,033$8.06 $40.6K22,740,305SEC↗
Lo Andrew10% Owner P Buy2019-05-222019-05-235,033$8.06 $40.6K22,740,305SEC↗
QVT Associates GP LLC10% Owner P Buy2019-05-222019-05-235,033$8.06 $40.6K22,740,305SEC↗
Machado Patrick10% Owner P Buy2019-05-222019-05-235,033$8.06 $40.6K22,740,305SEC↗
HALVORSEN OLE ANDREAS10% Owner P Buy2019-05-222019-05-235,033$8.06 $40.6K22,740,305SEC↗
Ott David C.10% Owner P Buy2019-05-222019-05-235,033$8.06 $40.6K22,740,305SEC↗
SoftBank Vision Fund L.P.10% Owner P Buy2019-05-222019-05-235,033$8.06 $40.6K22,740,305SEC↗
Dexxon Holdings Ltd.10% Owner P Buy2019-05-222019-05-285,033$8.06 $40.6K22,740,305SEC↗
Dexxon Holdings Ltd.10% Owner P Buy2019-05-212019-05-239,995$8.52 $85.2K22,735,272SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-212019-05-239,995$8.52 $85.2K22,735,272SEC↗
Lo Andrew10% Owner P Buy2019-05-212019-05-239,995$8.52 $85.2K22,735,272SEC↗
QVT Associates GP LLC10% Owner P Buy2019-05-212019-05-239,995$8.52 $85.2K22,735,272SEC↗
Machado Patrick10% Owner P Buy2019-05-212019-05-239,995$8.52 $85.2K22,735,272SEC↗
HALVORSEN OLE ANDREAS10% Owner P Buy2019-05-212019-05-239,995$8.52 $85.2K22,735,272SEC↗
Ott David C.10% Owner P Buy2019-05-212019-05-239,995$9995.00 $99.90M22,735,272SEC↗
SoftBank Vision Fund L.P.10% Owner P Buy2019-05-212019-05-239,995$8.52 $85.2K22,735,272SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-202019-05-201,715$8.39 $14.4K22,725,277SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-202019-05-208,285$7.98 $66.1K22,723,562SEC↗
Machado Patrick10% Owner P Buy2019-05-202019-05-208,285$7.98 $66.1K22,723,562SEC↗
Machado Patrick10% Owner P Buy2019-05-202019-05-201,715$8.39 $14.4K22,725,277SEC↗
QVT Associates GP LLC10% Owner P Buy2019-05-202019-05-208,285$7.98 $66.1K22,723,562SEC↗
QVT Associates GP LLC10% Owner P Buy2019-05-202019-05-201,715$8.39 $14.4K22,725,277SEC↗
Lo Andrew10% Owner P Buy2019-05-202019-05-201,715$8.39 $14.4K22,725,277SEC↗
Lo Andrew10% Owner P Buy2019-05-202019-05-208,285$7.98 $66.1K22,723,562SEC↗
SVF Investments (UK) Ltd10% Owner P Buy2019-05-202019-05-208,285$7.98 $66.1K22,723,562SEC↗
SVF Investments (UK) Ltd10% Owner P Buy2019-05-202019-05-201,714$8.39 $14.4K22,725,277SEC↗
HALVORSEN OLE ANDREAS10% Owner P Buy2019-05-202019-05-208,285$7.98 $66.1K0SEC↗
HALVORSEN OLE ANDREAS10% Owner P Buy2019-05-202019-05-201,715$8.39 $14.4K0SEC↗
Viking Global Opportunities Il10% Owner P Buy2019-05-202019-05-201,715$8.39 $14.4K0SEC↗
Viking Global Opportunities Il10% Owner P Buy2019-05-202019-05-208,285$7.98 $66.1K0SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-05-202019-05-221,715$8.39 $14.4K22,725,277SEC↗
Dexcel Pharma Technologies Ltd10% Owner P Buy2019-05-202019-05-228,285$7.98 $66.1K22,723,562SEC↗
Dexxon Holdings Ltd.10% Owner P Buy2019-05-172019-05-206,200$7.36 $45.6K22,715,277SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-172019-05-206,200$7.36 $45.6K22,715,277SEC↗
Machado Patrick10% Owner P Buy2019-05-172019-05-206,200$7.36 $45.6K22,715,277SEC↗
QVT Associates GP LLC10% Owner P Buy2019-05-172019-05-206,200$7.36 $45.6K22,715,277SEC↗
Lo Andrew10% Owner P Buy2019-05-172019-05-206,200$7.36 $45.6K22,715,277SEC↗
SVF Investments (UK) Ltd10% Owner P Buy2019-05-172019-05-206,200$7.36 $45.6K22,715,277SEC↗
HALVORSEN OLE ANDREAS10% Owner P Buy2019-05-172019-05-206,200$7.36 $45.6K0SEC↗
Viking Global Opportunities Il10% Owner P Buy2019-05-172019-05-206,200$7.36 $45.6K0SEC↗
Dexxon Holdings Ltd.10% Owner P Buy2019-05-162019-05-205,408$6.79 $36.7K22,709,077SEC↗
Roivant Sciences Ltd.10% Owner P Buy2019-05-162019-05-205,408$6.79 $36.7K22,709,077SEC↗
Machado Patrick10% Owner P Buy2019-05-162019-05-205,408$6.79 $36.7K22,709,077SEC↗
QVT Associates GP LLC10% Owner P Buy2019-05-162019-05-205,408$6.79 $36.7K22,709,077SEC↗
Lo Andrew10% Owner P Buy2019-05-162019-05-205,408$6.79 $36.7K22,709,077SEC↗
SVF Investments (UK) Ltd10% Owner P Buy2019-05-162019-05-205,408$6.79 $36.7K22,709,077SEC↗